563 related articles for article (PubMed ID: 17601891)
1. Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families.
Chen LM; Yang KY; Little SE; Cheung MK; Caughey AB
Obstet Gynecol; 2007 Jul; 110(1):18-25. PubMed ID: 17601891
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.
Schmeler KM; Lynch HT; Chen LM; Munsell MF; Soliman PT; Clark MB; Daniels MS; White KG; Boyd-Rogers SG; Conrad PG; Yang KY; Rubin MM; Sun CC; Slomovitz BM; Gershenson DM; Lu KH
N Engl J Med; 2006 Jan; 354(3):261-9. PubMed ID: 16421367
[TBL] [Abstract][Full Text] [Related]
4. Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implications for gynecologic surveillance.
Brown GJ; St John DJ; Macrae FA; Aittomäki K
Gynecol Oncol; 2001 Mar; 80(3):346-9. PubMed ID: 11263929
[TBL] [Abstract][Full Text] [Related]
5. Occult endometrial cancer and decision making for prophylactic hysterectomy in hereditary nonpolyposis colorectal cancer patients.
Pistorius S; Kruger S; Hohl R; Plaschke J; Distler W; Saeger HD; Schackert HK
Gynecol Oncol; 2006 Aug; 102(2):189-94. PubMed ID: 16476474
[TBL] [Abstract][Full Text] [Related]
6. Screening and prevention of hereditary gynecologic cancers.
Kehoe SM; Kauff ND
Semin Oncol; 2007 Oct; 34(5):406-10. PubMed ID: 17920895
[TBL] [Abstract][Full Text] [Related]
7. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
[TBL] [Abstract][Full Text] [Related]
8. Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma.
Collins V; Meiser B; Gaff C; St John DJ; Halliday J
Cancer; 2005 Jul; 104(2):273-81. PubMed ID: 15948171
[TBL] [Abstract][Full Text] [Related]
9. Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome.
Lu KH; Dinh M; Kohlmann W; Watson P; Green J; Syngal S; Bandipalliam P; Chen LM; Allen B; Conrad P; Terdiman J; Sun C; Daniels M; Burke T; Gershenson DM; Lynch H; Lynch P; Broaddus RR
Obstet Gynecol; 2005 Mar; 105(3):569-74. PubMed ID: 15738026
[TBL] [Abstract][Full Text] [Related]
10. [Endometrial cancer in HNPCC syndrome].
Lécuru F; Ansquer Y; Bats AS; Olschwang S; Laurent-Puig P; Eisinger F
J Gynecol Obstet Biol Reprod (Paris); 2008 Oct; 37(6):547-53. PubMed ID: 18650032
[TBL] [Abstract][Full Text] [Related]
11. Hereditary nonpolyposis colorectal cancer--Lynch syndromes I and II.
Lynch HT; Lanspa SJ; Boman BM; Smyrk T; Watson P; Lynch JF; Lynch PM; Cristofaro G; Bufo P; Tauro AV
Gastroenterol Clin North Am; 1988 Dec; 17(4):679-712. PubMed ID: 3068137
[TBL] [Abstract][Full Text] [Related]
12. How should women with a genetic predisposition for cancer be managed?
Hoskins WJ
Obstet Gynecol; 2007 Jul; 110(1):5-6. PubMed ID: 17601888
[No Abstract] [Full Text] [Related]
13. Prophylactic oophorectomy in women at increased cancer risk.
Domchek SM; Rebbeck TR
Curr Opin Obstet Gynecol; 2007 Feb; 19(1):27-30. PubMed ID: 17218848
[TBL] [Abstract][Full Text] [Related]
14. Hereditary non-polyposis colorectal cancer or Lynch syndrome: the gynaecological perspective.
Manchanda R; Menon U; Michaelson-Cohen R; Beller U; Jacobs I
Curr Opin Obstet Gynecol; 2009 Feb; 21(1):31-8. PubMed ID: 19125001
[TBL] [Abstract][Full Text] [Related]
15. A cost-effectiveness analysis of prophylactic surgery versus gynecologic surveillance for women from hereditary non-polyposis colorectal cancer (HNPCC) Families.
Yang KY; Caughey AB; Little SE; Cheung MK; Chen LM
Fam Cancer; 2011 Sep; 10(3):535-43. PubMed ID: 21538078
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of occult gynecologic malignancy at the time of risk reducing and nonprophylactic surgery in patients with Lynch syndrome.
Lachiewicz MP; Kravochuck SE; O'Malley MM; Heald B; Church JM; Kalady MF; Drake RD
Gynecol Oncol; 2014 Feb; 132(2):434-7. PubMed ID: 24211399
[TBL] [Abstract][Full Text] [Related]
17. The gynecological surveillance of women with Lynch syndrome in Sweden.
Tzortzatos G; Andersson E; Soller M; Askmalm MS; Zagoras T; Georgii-Hemming P; Lindblom A; Tham E; Mints M
Gynecol Oncol; 2015 Sep; 138(3):717-22. PubMed ID: 26177554
[TBL] [Abstract][Full Text] [Related]
18. The epidemiology of endometrial cancer in hereditary nonpolyposis colorectal cancer.
Vasen HF; Watson P; Mecklin JP; Jass JR; Green JS; Nomizu T; Müller H; Lynch HT
Anticancer Res; 1994; 14(4B):1675-8. PubMed ID: 7979205
[TBL] [Abstract][Full Text] [Related]
19. Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
Lamb JD; Garcia RL; Goff BA; Paley PJ; Swisher EM
Am J Obstet Gynecol; 2006 Jun; 194(6):1702-9. PubMed ID: 16731090
[TBL] [Abstract][Full Text] [Related]
20. Impact of gynecological screening in Lynch syndrome carriers with an MSH2 mutation.
Stuckless S; Green J; Dawson L; Barrett B; Woods MO; Dicks E; Parfrey PS
Clin Genet; 2013 Apr; 83(4):359-64. PubMed ID: 22775459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
